Hyperfine (NASDAQ:HYPR – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, May 13th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Hyperfine has set its Q1 2024 guidance at EPS and its FY 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.
Hyperfine (NASDAQ:HYPR – Get Free Report) last announced its quarterly earnings data on Thursday, March 21st. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.02. The company had revenue of $2.69 million during the quarter, compared to the consensus estimate of $3.66 million. Hyperfine had a negative net margin of 401.00% and a negative return on equity of 44.89%. On average, analysts expect Hyperfine to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Hyperfine Stock Up 1.3 %
Shares of HYPR stock opened at $0.81 on Monday. Hyperfine has a 52-week low of $0.77 and a 52-week high of $3.28. The firm’s 50-day moving average is $1.01 and its 200-day moving average is $1.11.
Wall Street Analyst Weigh In
Check Out Our Latest Report on HYPR
About Hyperfine
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Read More
- Five stocks we like better than Hyperfine
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Insider Trades May Not Tell You What You Think
- 3 Value Stocks You Can Buy Before They Become Big
- How to Buy Cheap Stocks Step by Step
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.